Press Release November 20, 2021DICERNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dicerna Pharmaceuticals, Inc. - DRNA 0 0 Share
Company Ticker News November 19, 2021Novo Nordisk Enhances Metabolic Disorder Pipeline With RNAi Drug Maker Dicerna 0 0 Share
Company Ticker News November 12, 2021EMA Backs Approval Of Novo Nordisk's Ozempic 2mg Dose For Diabetes 0 0 Share
Press Release November 6, 2021Novo Nordisk A/S purchases B shares worth DKK 4,109 million from Novo Holdings A/S under the 2021 share repurchase programme 0 0 Share
Press Release November 6, 2021Trading in Novo Nordisk shares by board members, executives and associated persons on 5 November 2021 0 0 Share
Company Ticker News November 4, 2021Novo Nordisk A/S (NVO) CEO Lars Fruergaard Jorgensen on Q3 2021 Results - Earnings Call Transcript 0 0 Share
Company Ticker News October 29, 2021Novo Nordisk raises sales and operating profit outlook for 2021 0 0 Share
